Abstract:The successful introduction of antibody-based immunotherapies into the arsenal of treatments for cancer patients has been reinvigorated by antibody engineering technology. New antitumor strategies include enhancement of T-cell responses provided by monoclonal antibody activation of costimulatory molecules present on T-cell surface. OX40, a member of the TNF receptor superfamily (TNRFS4), is a key T-cell costimulator and a promising cancer immunotherapy target. Currently, several pharmaceutical companies have i… Show more
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.